Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
McKinsey
Dow
Colorcon

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Granules Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GRANULES PHARMS, and what generic and branded alternatives to GRANULES PHARMS drugs are available?

GRANULES PHARMS has four approved drugs.



Summary for Granules Pharms
US Patents:0
Tradenames:3
Ingredients:3
NDAs:4

Drugs and US Patents for Granules Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Granules Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET, EXTENDED RELEASE;ORAL 210992-002 Nov 21, 2018 AB RX No No   Start Trial   Start Trial
Granules Pharms METHYLERGONOVINE MALEATE methylergonovine maleate TABLET;ORAL 210424-001 May 15, 2018 AB RX No No   Start Trial   Start Trial
Granules Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 211796-001 May 23, 2019 AB1 RX No No   Start Trial   Start Trial
Granules Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 211796-004 May 23, 2019 AB1 RX No No   Start Trial   Start Trial
Granules Pharms AMPHETAMINE SULFATE amphetamine sulfate TABLET;ORAL 212619-002 Aug 5, 2019 AA RX No No   Start Trial   Start Trial
Granules Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 211796-005 May 23, 2019 AB1 RX No No   Start Trial   Start Trial
Granules Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 211796-003 May 23, 2019 AB1 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Mallinckrodt
Express Scripts
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.